Under control of the Ren-1(c) promoter, locally produced transforming growth factor-β1 induces accumulation of glomerular extracellular matrix in transgenic mice

Diabetes

Volumn 48, Issue 1, 1999, Pages 182-192

  Wogensen, Lise ^a,b   Nielsen, Camilla Birch ^a   Hjorth, Peter ^c   Rasmussen, Lars Melholt ^b   Nielsen, Arne Høj ^d   Gross, Kenneth ^e   Sarvetnick, Nora ^f   Ledet, Thomas ^a  

^a Institute of Experimental Clinical Research   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; COLLAGEN TYPE 4; COMPLEMENTARY DNA; LAMININ; TRANSFORMING GROWTH FACTOR BETA1; PROTEOGLYCAN; RENIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE SEVERITY; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; TRANSGENIC MOUSE; ANIMAL; ANIMAL BEHAVIOR; BIOSYNTHESIS; CULTURE TECHNIQUE; DRUG EFFECT; GENE EXPRESSION; GENETICS; GLOMERULUS; KIDNEY; METABOLISM; MOUSE STRAIN; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; TRANSGENE;

ANIMALS; BEHAVIOR, ANIMAL; CULTURE TECHNIQUES; EXTRACELLULAR MATRIX; GENE EXPRESSION; KIDNEY; KIDNEY GLOMERULUS; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); PROTEOGLYCANS; RENIN; TRANSFORMING GROWTH FACTOR BETA; TRANSGENES;

EID: 0032589897     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.1.182     Document Type: Article

References (47)

1. Mogensen C-E: Definition of diabetic renal disease in insulin-dependent diabetes mellitus based on renal function tests. In The Kidney and Hypertension in Diabetes Mellitus. Mogensen C-E, Ed. Boston, Kluwer Academic, 1997, p. 11-22
2. Olsen S: Light microscopy of diabetic nephropathy: the classical lesions. In The Kidney and Hypertension in Diabetes Mellitus. Mogensen C-E, Ed. Boston, Kluwer Academic, 1997, p. 173-183
3. Nerlich A, Schleicher E: Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 139:889-899, 1991
4. Tamsma JT, Bruin J : Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37:313-320, 1994
5. Sharma K, Ziyadeh FN: The emerging role of transforming growth factor-beta in kidney diseases (Editorial). Am J Physiol 266:F829-F842, 1994
6. Border WA, Yamamoto T, Noble NA: Transforming growth factor-β in diabetic nephropathy. Diabetes Metab Rev 12:309-339, 1996
7. Border WA, Noble NA: TGF-β in kidney fibrosis: a target for gene therapy. Kidney Int 51:1388-1390, 1997
8. Nakamura T, Miller D, Ruoslahti E, Border WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. Kidney Int 41:1213-1221, 1992
9. Pearson CA, Pearson D, Shibahara S, Hofsteenge J, Chiquet Ehrismann R: Tenascin: cDNA cloning and induction by TCP-beta. EMBO J 7:2977-2982, 1988
10. Wang A, Cohen DS, Palmer E, Sheppard D: Polarized regulation of fibronectin secretion and alternative splicing by transforming growth factor. J Biol Chem 266:15598-15601, 1991
11. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 93:536-542, 1994
12. Lund LR, Riccio A, Andreasen PA, Nielsen LS, Kristensen P, Laiho M, Saksela O, Blasi F, Danø K: Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J 6:1281-1286, 1987
13. Sawdey M, Podor TJ, Loskutoff DJ: Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells: induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha. J Biol Chem 264:10396-10401, 1989
14. Laiho M, Saksela O, Andreasen PA, Keski Oja J: Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol 103:2403-2410, 1986
15. Pfeiffer A, Middelberg-Bisping K, Drewes C, Schatz H: Elevated plasma levels of transforming growth factor-βl1 in NIDDM. Diabetes Care 19:1113-1117, 1996
16. Iwano M, Kuho A, Nishino T, Sato H, Nishioka H, Akai Y, Kurioka H, Fujii Y, Kanauchi M, Shiiki H, Dohi K: Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus. Kidney Int 49:1120-1126, 1996
17. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A 90:1814-1818, 1993
18. Sharma K, Ziyadeh FN, Alzahab B, McGowan TA, Kapoor S, Kurnik BRC, Kurnik PB, Weisberg LS: Increased renal production of transforming growth factor-β1 in patients with type II diabetes. Diabetes 46:854-859, 1997
19. Sharma K, Ziyadeh FN: Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol 267:F1094-F1101, 1994
20. Yang CW, Hattori M, Vlassara H, He CJ, Carome MA, Yamato E, Elliot S, Striker GE, Striker LJ: Overexpression of transforming growth factor-beta 1 mRNA is associated with up-regulatiou of glomerular tenascin and laminin gene expression in nonobese diabetic mice. J Am Soc Nephrol 5:1610-1617, 1995
21. Shankland SJ, Scholey JW, Ly H, Thai K: Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy. Kidney Int 46:430-442, 1994
22. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530, 1996
23. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta. Kidney Int 42:647-656, 1992
24. van Del NF, Verhagen NAM, Tamsma JT, Borden JHM, Bruijn JA, Daha MR, van der Woude FJ: Regulation of glomerular epithelial cell production of fibronectin and transfonning growth fartor-β by high glucose, not by angiotensin II. Diabetes 46:834-840, 1997
25. 1 enhances glomerular collagen synthesis in diabetic rats. Dibetes 42:1673-1677, 1993
26. Sigmund CD, Gross KW: Structure, expression, and regulation of the murine renin genes. Hypertension 18:446-457, 1991
27. Petrovic N, Black TA, Fabian JR, Kane C, Jones CA, Loudon JA, Abonia JP, Sigmund CD, Gross KW: Role of proximal promoter elements in regulation of renin gene transcription. J Biol Chem 271:22499-22505, 1997
28. Massague J: The TGF-beta family of growth and differentiation factors. Cell 49:437-438, 1987
29. Hogan B, Constantini F, Lacy E: Manipulating the Mouse Embryo: A Laboratory Manual. Cold Springs Harbor, NY, Cold Spring Harbor Laboratory Press, 1986
30. Sigmund CD, Jones CA, Kane CM, Wu C, Lang JA, Gross KW: Regulated tissue- and cell-specific expression of the human renin gene in transgenic mice. Circ Res 70:1070-1079, 1992
31. Poulsen K, Jørgensen J: An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping antibody. J Clin Endocrinol Metab 39:816-825, 1974
32. Lowry HO, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275, 1951
33. Taugner C, Poulsen K, Hackenthal E, Taugner R: Immunocytoehemical localization of renin in mouse kidney. Histochemistry 62:19-27, 1979
34. Malling C, Poulsen K: A direct radioimnnmoassay for plasma renin in the mice and its evaluation. Biochem Biophys Res Commun 491:532-541, 1977
35. Wyss-Coray T, Feng L, Masliah E, Ruppe MD, Lee HS, Toggas SM, Rockenstein EM, Mucke L: Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1. Am J Pathol 147:53-67, 1995
36. Border WA, Okuda S, Languino LR, Ruoslahti E: Transforming growth factor-beta regulates production of proteoglycans by mesangial cells. Kidney Int 37:689-695, 1990
37. Kim SJ, Denhez F, Kim K-Y, Holt JT, Sporn MB, Roberts AB: Activation of the second promoter of the transforming growth factor-β1 gene by transforming growth factor-β1 and phorbol ester occurs through the same target sequences. J Biol Chem 264:1937-19378, 1989
38. Park IS, Kiyomoto H, Abboud SL, Abboud HE : Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46:473-480, 1997
39. Brinster RL, Allen JM, Behringer RR, Gelinas RE, Palmiter RD: Introns increase transcriptional efficiency in transgenic mice. Proc Natl Acad Sci U S A 85:836-840, 1988
40. Allison J, Malcom L, Culvenor J, Bartholomeusz RK, Holmberg K, Miller JFAP: Overexpression of β2-microglobulin in transgenic mouse islet β-cell result in defective insulin secretion. Proc Natl Acad Sci U S A 88:2070-2074, 1991
41. Lo D, Burkly LC, Widera G, Cowing C, Flavell RA, Palmiter RD, Brinster RL: Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell 53:159-168, 1988
42. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92:2597-2601, 1993
43. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE, Thorgeirsson SS: Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 74:991-1003, 1996
44. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS: Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A 92:2572-2576, 1995
45. Clouthier DE, Comerford SA, Hammer RE: Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-β1 transgenic mice. J Clin Invest 100:2697-2713, 1997
46. Velasquez MT, Kimmel PL, Michaelis OE IV: Animal models of spontaneous diabetic kidney disease. FASEB J 4:2850-2859, 1990
47. Østerby R, Parving HH, Hommel E, Jørgensen HE, Løkkegaard H: Glomerular structure and function in diabetic nephropathy: early to advanced stages. Diabetes 39:1057-1063, 1990